Delivery Order SPE2DB22D2006-SPE2DB24FW1TA

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $80K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a firm fixed price and a ceiling value of $2,756.06. It is not designated as a set-aside contract. The contract serves as a delivery order under a larger Indefinite Delivery Contract (IDC) held...
This is a $1,747.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 80-12.5 MG TB UD 30S, a cardiovascular medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,749.34 firm fixed-price contract is for the supply of 4563061798 TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2023. This order is placed against AmerisourceBergen's...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,282.36 firm fixed-price contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $4,185.78, is for the provision of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The award has a ceiling value of $5,963.04 and a period of performance through February 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TELMISARTAN-HCTZ 80-12.5 MG TB UD 30S medication. The contract has a ceiling value of $3,560.75 and a period of performance ending on March 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
This is a $35,525.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of March 12, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,775.61, is a delivery order for the supply of 4566659455 TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 10, 2024. The award is not designated as a set-aside contract. This contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $17,101.19 firm fixed-price contract is for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a performance period through January 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1TA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $79,696.86, is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a period of performance through July 10, 2024 and is a firm fixed-price contract type. This contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this specific contract award.

Generated 5/17/25, 9:59 AM